Christine Defer

893 total citations
19 papers, 681 citations indexed

About

Christine Defer is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Christine Defer has authored 19 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 7 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Christine Defer's work include Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Christine Defer is often cited by papers focused on Hepatitis C virus research (9 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). Christine Defer collaborates with scholars based in France, Australia and Netherlands. Christine Defer's co-authors include Pierre Boulanger, Marie‐Laure Caillet‐Boudin, Benoît Flan, Michel Vidaud, Jean‐Thierry Aubin, J. Coste, Jean–Michel Pawlotsky, Françoise Bouchardeau, Philippe M. Loiseau and Syria Laperche and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and Journal of Hepatology.

In The Last Decade

Christine Defer

19 papers receiving 647 citations

Peers

Christine Defer

EPIDE

GENET

HEPAT

Anne Halenius Germany

Pong Kian Chua United States

Jonas Söderholm Sweden

Élodie Beaumont France

Isabel Gallego Spain

Michael J. Fuller United States

Kuei-Hsiang Lin Taiwan

Astrid Meerbach Germany

Åke Espmark Sweden

Ganesh R. Talekar United States

Anne Halenius Germany

Christine Defer

675 ×2.6

EPIDE

104 ×0.4

73 ×0.3

GENET

150 ×0.7

HEPAT

278 ×1.5

Citations per year, relative to Christine Defer Christine Defer (= 1×) peers Anne Halenius

Countries citing papers authored by Christine Defer

Since Specialization

Citations

This map shows the geographic impact of Christine Defer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Defer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Defer more than expected).

Fields of papers citing papers by Christine Defer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Defer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Defer. The network helps show where Christine Defer may publish in the future.

Co-authorship network of co-authors of Christine Defer

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Defer. A scholar is included among the top collaborators of Christine Defer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Defer. Christine Defer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Guiraud, Vincent, et al.. (2024). Sensitivity and specificity of the new Bio-Rad HIV screening test, Access HIV combo V2. Journal of Clinical Microbiology. 62(5). e0009524–e0009524. 1 indexed citations

Defer, Christine, et al.. (2013). Proteomics applied to transfusion plasma: the beginning of the story. Vox Sanguinis. 104(4). 275–291. 3 indexed citations

Morel, Pascal, et al.. (2006). Sécurité des produits sanguins labiles et parvovirus B19. Transfusion Clinique et Biologique. 13(4). 235–241. 10 indexed citations

Fournier‐Wirth, Chantal, Marie Deschaseaux, Christine Defer, et al.. (2005). Evaluation of the enhanced bacterial detection system for screening of contaminated platelets. Transfusion. 46(2). 220–224. 31 indexed citations

Laperche, Syria, et al.. (2003). A new HCV core antigen assay based on disassociation of immune complexes: an alternative to molecular biology in the diagnosis of early HCV infection. Transfusion. 43(7). 958–962. 47 indexed citations

Lucidarme, Damien, A. Decoster, Catherine Delamare, et al.. (2003). [An inter-laboratory study of anti-HCV antibody detection in saliva samples].. PubMed. 27(2). 159–62. 7 indexed citations

Lelie, P.N., H. T. M. Cuypers, Susan J. Best, et al.. (2002). Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion. 42(5). 527–536. 47 indexed citations

Aubin, Jean‐Thierry, et al.. (2000). Large–Scale Screening for Human Parvovirus B19 DNA by PCR: Application to the Quality Control of Plasma for Fractionation. Vox Sanguinis. 78(1). 7–12. 53 indexed citations

Lemaire, J.M., AM Couroucé, Christine Defer, et al.. (2000). HCV RNA in blood donors with isolated reactivities by third‐generation RIBA. Transfusion. 40(7). 867–870. 14 indexed citations

10.

Aubin, Jean‐Thierry, et al.. (2000). Large‐Scale Screening for Human Parvovirus B19 DNA by PCR: Application to the Quality Control of Plasma for Fractionation. Vox Sanguinis. 78(1). 7–12. 43 indexed citations

11.

Martinot-Peignoux, Michelle, F Roudot-Thoraval, Isabelle Mendel, et al.. (1999). Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. Journal of Viral Hepatitis. 6(6). 435–443. 102 indexed citations

12.

Saura, C., A.M. Couroucé, Josiane Pillonel, et al.. (1999). Risk–Benefit Analysis of Nucleic Acid Testing: The French Experience. Biologicals. 27(4). 343–348. 6 indexed citations

13.

Lefrère, Jean‐Jacques, Jean‐François Cantaloube, Christine Defer, et al.. (1999). Screening for HBV, HCV and HIV genomes in blood donations: shortcomings of pooling revealed by a multicentre study simulating real-time testing. Journal of Virological Methods. 80(1). 33–44. 13 indexed citations

14.

Jj, Lefrère, J. Coste, Christine Defer, et al.. (1998). Screening blood donations for viral genomes: multicenter study of real‐ time simulation using pooled samples on the model of hepatitis C virus RNA detection. Transfusion. 38(10). 915–923. 20 indexed citations

15.

Lucidarme, Damien, Jean‐Pierre Arpurt, E A Pariente, et al.. (1998). [Rapid progress of cirrhosis in hepatitis C: the role of age at the time of viral contamination].. PubMed. 27(13). 608–11. 2 indexed citations

16.

Defer, Christine, J. Coste, Sophie Voisin, et al.. (1995). Contribution of polymerase chain reaction and radioimmunoprecipitation assay in the confirmation of human T‐lymphotropic virus infection in French blood donors. Transfusion. 35(7). 596–600. 11 indexed citations

17.

Lamoril, J., Pierre Laurent‐Puig, Christine Defer, et al.. (1994). Indeterminate third-generation recombinant immunoblot assay in hepatitis C virus infection. Journal of Hepatology. 21(1). 133–134. 7 indexed citations

18.

Defer, Christine, et al.. (1992). Multicentre quality control of polymerase chain reaction for detection of HIV DNA. AIDS. 6(7). 659–664. 36 indexed citations

19.

Defer, Christine, et al.. (1990). Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. Journal of Virology. 64(8). 3661–3673. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact